Navigation Links
Blood Thinners May Boost Survival for Prostate Cancer Patients: Study
Date:2/21/2013

By Denise Mann
HealthDay Reporter

THURSDAY, Feb. 21 (HealthDay News) -- Men with advanced prostate cancer might live longer when they are taking blood-thinning medication, a small study suggests.

Prostate cancer patients who were also taking a blood thinner, usually to stave off a blood clot, had a 39 percent increase in overall survival over men who were not taking these drugs, report researchers from the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore.

But the study authors and outside experts caution that blood thinners can't be prescribed routinely to cancer patients, as they confer risks including bleeding, although men who need an anticoagulant might also find it beneficial in terms of prostate cancer. The findings were presented this month by Caroline Pratz and colleagues at an American Society of Clinical Oncology (ASCO) conference in Orlando, Fla.

The U.S. National Cancer Institute estimates that this year almost 239,000 new cases of prostate cancer will be diagnosed in the United States, and nearly 30,000 men will die from the disease.

The new study included almost 250 men with advanced or spreading prostate cancer who were receiving chemotherapy. Of these, 11.7 percent were also taking a blood thinner to prevent potentially fatal blood clots that could detach and reach their lungs, known as a pulmonary embolism. The men taking blood thinners -- heparin and warfarin were included -- survived for about 21 months, compared to slightly more than 17 months for men who were not taking blood thinners.

The finding was surprising, because the researchers thought venous thromboembolism -- clots deep in the leg veins -- would negatively affect overall survival.

But how or even if the blood-thinning medications could confer a survival edge is unknown. The study only shows an association, it does not show that it's the blood thinners themselves that made the difference, said Dr. Cy Stein, an oncologist at the City of Hope Medical Center in Duarte, Calif., who was not involved with the study.

"Maybe men who develop blood clots have something else that affects how they respond to chemotherapy. We just don't know," Stein said.

Another expert said this is not the first time that blood thinners, including aspirin (which was not included in the new study), have been linked to improved survival for men with prostate cancer.

"Most of the data comes out of studies where oncology patients are being treated with blood thinners to prevent blood clots and incidentally there was some improvement in survival," said Dr. Manish Vira, director of the fellowship program in urologic oncology at North Shore-LIJ's Arthur Smith Institute for Urology in Lake Success, N.Y.

The new findings are "thought-provoking, but we should not just go ahead and treat everyone with cancer with blood thinners based on this study," he said.

Further research is needed, agreed Dr. Eric Singer, a urologic oncologist at the Cancer Institute of New Jersey and assistant professor of surgery at UMDNJ-Robert Wood Johnson Medical School in New Brunswick, N.J. "There is evidence from a number of studies suggesting that blood thinners might interact in some different ways with cancer and its treatment," Singer said.

"The guys who were getting [blood thinners] did better and something could be going on there, but keep in mind that being on a blood thinner comes with a risk of bleeding and stroke and should not be used lightly," Singer added.

More work is needed to confirm the results, and then to determine the ideal anticoagulant as well as the dose, timing and related risks, the study authors said.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCES: Cy A. Stein, M.D., Ph.D., Arthur and Rosalie Kaplan Professor and chair, department of medical oncology and experimental therapeutics and deputy director of clinical research, City of Hope Medical Center, Duarte, Calif.; Manish A. Vira, director, fellowship program in urologic oncology, North Shore-LIJ Arthur Smith Institute for Urology, Lake Success, N.Y.; Eric A. Singer, M.D., M.A., urologic oncologist, the Cancer Institute of New Jersey and assistant professor of surgery, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, N.J.; presentation, February 2013, American Society of Clinical Oncology conference, Orlando, Fla.


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Save the Date Durand Community Blood Drives at the American Legion with the Rock River Valley Blood Center
2. New Blood Thinner Beats Older Drug for Vein Clots: Study
3. Children’s Cancer & Blood Foundation to Host Private Party at American Girl Place, New York City
4. Damage to Tiny Blood Vessels in Brain May Raise Alzheimers Risk
5. NuvaRing Lawsuit Filed on Behalf of a South Carolina Woman who Developed Two Blood Clots While Using NuvaRing, Reports Wright & Schulte LLC
6. US Drug Watchdog Now Urges All DePuy ASR And Pinnacle All Metal Hip Implant Recipients To Get A Blood Test And To Call Them Before The Time Runs Out To Get Identified
7. STEMSOFT and The Canadian Blood and Marrow Transplant Group Announce Partnership
8. High Blood Pressure in Pregnancy May Predict Later Ills, Study Says
9. NuvaRing Blood-Clotting Victims Still Eligible to File Lawsuits Through Resource4thePeople
10. Blood-based test detects cancer earlier, from the February 2013 Harvard Health Letter
11. Scientists discover protein that allows safe recycling of iron from old red blood cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Thinners May Boost Survival for Prostate Cancer Patients: Study
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & ... (TGIG), has initiated cultivation and processing operations at its production facility, and opened ... , Puradigm is the manufacturer of a complete system of proactive air and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology: